Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
600671
Rank in Stocks
#14532
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, a company founded in... Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, a company founded in 1958 and based in Hangzhou, China, operates a multifaceted business primarily focused on the pharmaceutical sector. Through its various subsidiaries, the company specializes in both the production and distribution of medicines throughout China. Its extensive product range includes the manufacturing and sale of a diverse array of pharmaceuticals and health-related goods. These encompass various dosage forms such as tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, and soft capsules, as well as a selection of health foods. Beyond finished products, Hangzhou TianMuShan is also involved in the trade of raw materials like menthol and peppermint oil. The company also offers a comprehensive selection of traditional Chinese medicine, including prepared formulas, individual herbal pieces, and fresh herbs. Furthermore, it provides specialized medical services such as custom decoction preparation and delivery, herbal slicing and powder grinding, and traditional Chinese medicine diagnosis and treatment. In addition to its core pharmaceutical activities, the enterprise has diversified into other ventures, including software development, remote health management solutions, commercial property administration, food services, and internet information businesses.
Share Price
$2.59
Last synced: 2026-11-10
Market Cap
$315.36M
Change (1 day)
-0.23%
Change (1 year)
-2.98%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671)
Category
Healthcare
EPS for Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671)
EPS as of September 2026 TTM: $0.01
According to Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $0.02, equal to its 2024 EPS of $0.02.
EPS history for Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -29.00% |
| 2025 | $0.02 | 12.36% |
| 2024 | $0.02 | -140.64% |
| 2023 | $-0.04 | -45.04% |
| 2022 | $-0.08 | 110.85% |
| 2021 | $-0.04 | -25.15% |
| 2020 | $-0.05 | -183.75% |
| 2019 | $0.06 | -619.83% |
| 2018 | $-0.01 | -207.41% |
| 2017 | $0.01 | 671.43% |
| 2016 | 0.00 | -105.05% |
| 2015 | $-0.03 | -965.63% |
| 2014 | 0.00 | -3.03% |
| 2013 | 0.00 | -102.82% |
| 2012 | $-0.12 | -435.53% |
| 2011 | $0.03 | -429.25% |
| 2010 | $-0.01 | -83.17% |
| 2009 | $-0.06 | -1,531.82% |
| 2008 | 0.00 | -73.17% |
| 2007 | $0.02 | 0.00% |
| 2006 | 0.00 | -100.00% |
| 2005 | 0.00 | -45.95% |
| 2004 | $0.01 | -183.15% |
| 2003 | $-0.01 | -442.31% |
| 2002 | 0.00 | -18.75% |
| 2001 | 0.00 | -8.57% |
| 2000 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.89 | 217,435.21% |
US
|
|
| $6.60 | 46,378.87% |
US
|
|
| $5.83 | 40,956.34% |
US
|
|
| $18.54 | 130,477.46% |
CH
|
|
| $0.98 | 6,801.41% |
US
|
Questions about Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS)
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS)?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) over the last twelve months is $0.01, as of Sep 2026.
What was Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) in 2025?
In 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) was $0.02, about the same as in 2024 ($0.02).
How has Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) was highest in 2025 ($0.02) and lowest in 2022 ($-0.08).
How does Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) compare with similar companies?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with $30.89.